BU-NOT-SET

CONTACT US
Using blow-fill-seal technology for biologic and vaccine delivery
  • Drug product
  • Manufacturing
blow-fill-seal
Insight
Webinar: Understanding the benefits of blow-fill-seal unidose for ophthalmics, as an alternative to glass vials
vials
Webinar
A leading global CDMO, renowned for its reliable & on-time offerings
  • Industry trends
  • Manufacturing
two people looking at a document
Insight
Navigating challenges in progressing breakthrough RNA therapeutics
  • Biologics
RNA
Insight
Sustainability report 2023
  • Sustainability
Sustainability report
Report
Navigating pre-filled syringe filling complexities
  • Industry trends
  • Manufacturing
Syringes
Insight
New product introduction: key to getting innovations from pilot to product
  • Industry trends
  • Manufacturing
Lab people reading a paper
Insight
Tackling antimicrobial resistance
  • Drug product
Small bottles with antibiotics
Case study
A new centre for continuous mRNA manufacturing
  • Biologics
mRNA manufacture
Insight
Insight
  • Drug product
  • Industry trends
Three challenges pharma companies can overcome when choosing the right OSD partner
Insight
  • Sustainability
Sustainable pharmaceutical supply chains with the Science Based Targets initiative
Insight
How CDMO partnerships can accelerate vaccine development
Insight
  • Analytical chemistry
  • Drug product
Optimising extractables and leachables testing
Fact sheet
  • Drug product
  • Manufacturing
Ready-to-use (RTU) pre-filled syringes and cartridges system
Insight
  • Drug product
  • Manufacturing
Recipharm’s latest investment will help meet blow-fill-seal (BFS) demand
Insight
  • Drug product
  • Industry trends
Which biologics trends in the OSD space are set to impact drug development in 2023?
Insight
  • Drug product
  • Industry trends
What are the key learnings from 2022 in pharma?
Insight
  • Drug product
  • Manufacturing
Overcoming the pitfalls of pre-filled syringe filling